DAWN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.70%

Insider Buying (Last 12 Months): $30,187,281.49

Insider Selling (Last 12 Months): $30,790,138.54

Day One Biopharmaceuticals Insider Trading History Chart

Day One Biopharmaceuticals Share Price & Price History

^$20.45

▲ +1.24 (6.45%)

As of 09/28/2022 03:29 PM ET

Days: 30 | 90 | 365

Nevada Desert more Valuable than Wall Street or Silicon Valley?

From Investing Trends | Ad

It could be true, according to Nevada Governor Steve Sisolak. The state's desert flats contain more lithium than any other geography in the world. And with electric vehicles driving a global boom in demand for lithium-ion batteries, Nevada should be on every investor's radar.

Find Out How to Take Advantage of Nevada's Lithium

Day One Biopharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/21/2022	Julie Papanek Grant	Director	Sell	613,603	$18.55	$11,382,335.65	8,464,301
9/20/2022	Xi L.P. Canaan	Major Shareholder	Sell	148,670	$19.51	$2,900,551.70	9,077,904
9/19/2022	Julie Papanek Grant	Director	Sell	76,725	$20.57	$1,578,233.25	9,226,574
9/16/2022	Xi L.P. Canaan	Major Shareholder	Sell	115,307	$21.55	$2,484,865.85	9,303,299
9/15/2022	Julie Papanek Grant	Director	Sell	51,281	$22.85	$1,171,770.85	9,418,606
9/14/2022	Xi L.P. Canaan	Major Shareholder	Sell	106,111	$23.68	$2,512,708.48	9,469,887
9/13/2022	Julie Papanek Grant	Director	Sell	87,647	$24.40	$2,138,586.80	9,575,998
9/2/2022	Papanek Julie Grant	Director	Sell	5,000	$23.82	$119,100.00	439,358
8/16/2022	Charles N York II	CFO	Sell	1,089	$24.31	$26,473.59	324,401
8/16/2022	Jeremy Bender	CEO	Sell	4,003	$24.31	$97,312.93	1,252,875
8/16/2022	Samuel C. Blackman	Insider	Sell	941	$24.31	$22,875.71	1,299,338
8/4/2022	Charles N York II	CFO	Sell	10,000	$20.05	$200,500.00	321,365
8/4/2022	Jeremy Bender	CEO	Sell	12,500	$20.00	$250,000.00	1,246,192
8/4/2022	Papanek Julie Grant	Director	Sell	5,000	$20.00	$100,000.00	454,358
8/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$16.88	$168,800.00	1,296,718
7/18/2022	Charles N York II	CFO	Sell	2,500	$20.00	$50,000.00	331,365
7/18/2022	Papanek Julie Grant	Director	Sell	2,600	$20.00	$52,000.00	459,358
7/8/2022	Charles N York II	CFO	Sell	1,416	$20.00	$28,320.00	333,865
7/8/2022	Jeremy Bender	CEO	Sell	1,795	$20.00	$35,900.00	1,261,292
7/8/2022	Papanek Julie Grant	Director	Sell	1,242	$20.00	$24,840.00	461,958
7/5/2022	Charles N York II	CFO	Sell	800	$20.00	$16,000.00	335,281
7/5/2022	Jeremy Bender	CEO	Sell	857	$20.00	$17,140.00	1,263,087
7/1/2022	Charles N York II	CFO	Sell	1,479	$20.00	$29,580.00	336,081
7/1/2022	Jeremy Bender	CEO	Sell	1,746	$20.00	$34,920.00	1,263,944
7/1/2022	Papanek Julie Grant	Director	Sell	1,000	$20.00	$20,000.00	464,000
7/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$18.72	$187,200.00	1,306,718
6/17/2022	Ai Day1 Llc	Major Shareholder	Buy	1,200,000	$15.00	$18,000,000.00	10,684,638
6/17/2022	Michael Gladstone	Director	Buy	766,667	$15.00	$11,500,005.00	766,667
6/15/2022	Samuel C. Blackman	Insider	Sell	50,000	$16.26	$813,000.00	1,316,718
1/20/2022	Ai Day1 Llc	Major Shareholder	Buy	4,615	$14.73	$67,978.95
1/18/2022	Ai Day1 Llc	Major Shareholder	Buy	43,429	$14.26	$619,297.54
1/3/2022	Samuel C. Blackman	Insider	Sell	10,000	$17.10	$171,000.00
12/8/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	110,338	$18.03	$1,989,394.14
12/6/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	97,692	$18.05	$1,763,340.60
12/3/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	12,517	$18.47	$231,188.99
12/1/2021	Samuel C. Blackman	Insider	Sell	10,000	$17.22	$172,200.00

What The White House Is NOT Telling You About The "Green Revolution."

From Investing Trends | Ad

Read The Full Story On This "Gold Rush"

SEC Filings (Institutional Ownership Changes) for Day One Biopharmaceuticals (NASDAQ:DAWN)

95.40% of Day One Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Day One Biopharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/22/2022	ExodusPoint Capital Management LP	23,003	$0.41M	0.0%	N/A	0.031%
8/18/2022	Goldman Sachs Group Inc.	1,894,537	$33.91M	0.0%	+5,969.9%	2.579%
8/17/2022	Macquarie Group Ltd.	110,000	$1.97M	0.0%	N/A	0.150%
8/16/2022	Utah Retirement Systems	34,184	$0.61M	0.0%	-15.7%	0.047%
8/16/2022	Woodline Partners LP	150,176	$2.69M	0.0%	N/A	0.204%
8/16/2022	Price T Rowe Associates Inc. MD	2,041,344	$36.54M	0.0%	+28.7%	2.779%
8/16/2022	Commodore Capital LP	739,661	$13.24M	2.8%	N/A	1.007%
8/16/2022	Deerfield Management Company L.P. Series C	3,512,123	$62.87M	1.3%	+68.3%	4.781%
8/16/2022	Driehaus Capital Management LLC	501,689	$8.98M	0.1%	+24.3%	0.683%
8/15/2022	Occudo Quantitative Strategies LP	23,619	$0.42M	0.0%	N/A	0.032%
8/15/2022	State Street Corp	358,783	$6.42M	0.0%	+65.9%	0.488%
8/15/2022	Macquarie Group Ltd.	110,000	$1.97M	0.0%	N/A	0.150%
8/15/2022	Cubist Systematic Strategies LLC	61,237	$1.10M	0.0%	N/A	0.083%
8/15/2022	Laurion Capital Management LP	15,000	$0.27M	0.0%	-83.6%	0.020%
8/15/2022	Millennium Management LLC	17,555	$0.31M	0.0%	-90.0%	0.024%
8/13/2022	Quantbot Technologies LP	2,900	$51K	0.0%	N/A	0.004%
8/13/2022	Renaissance Technologies LLC	116,630	$2.09M	0.0%	N/A	0.159%
8/12/2022	Northern Trust Corp	190,510	$3.41M	0.0%	+11.9%	0.259%
8/12/2022	Virtus ETF Advisers LLC	6,551	$0.12M	0.0%	-26.3%	0.009%
8/12/2022	FMR LLC	6,826,574	$122.20M	0.0%	+163.1%	9.293%
8/12/2022	Franklin Resources Inc.	2,465,380	$44.13M	0.0%	+59.8%	3.356%
8/12/2022	Rhumbline Advisers	33,954	$0.61M	0.0%	+74.9%	0.046%
8/11/2022	UBS Group AG	3,851	$69K	0.0%	N/A	0.005%
8/11/2022	Alps Advisors Inc.	36,730	$0.66M	0.0%	-42.3%	0.050%
8/5/2022	State Board of Administration of Florida Retirement System	13,760	$0.25M	0.0%	N/A	0.019%
8/4/2022	TD Asset Management Inc.	46,333	$0.83M	0.0%	+23.7%	0.063%
8/3/2022	Atlas Venture Life Science Advisors LLC	8,968,305	$160.53M	26.8%	+9.3%	12.217%
7/29/2022	SG Americas Securities LLC	9,446	$0.17M	0.0%	N/A	0.013%
7/25/2022	Silverarc Capital Management LLC	105,476	$1.89M	0.6%	N/A	0.144%
7/19/2022	TCI Wealth Advisors Inc.	1,974	$35K	0.0%	N/A	0.003%
7/13/2022	ACG Wealth	1,772	$32K	0.0%	N/A	0.002%
6/30/2022	Amalgamated Bank	3,034	$30K	0.0%	N/A	0.004%
5/27/2022	Walleye Capital LLC	26,148	$0.26M	0.0%	N/A	0.042%
5/17/2022	Walleye Capital LLC	26,148	$0.26M	0.0%	N/A	0.042%
5/17/2022	RA Capital Management L.P.	6,060,090	$60.12M	1.3%	+22.0%	9.789%
5/16/2022	California State Teachers Retirement System	9,687	$96K	0.0%	+58.6%	0.016%
5/16/2022	Goldman Sachs Group Inc.	31,212	$0.31M	0.0%	+27.2%	0.050%
5/16/2022	Deerfield Management Company L.P. Series C	2,086,449	$20.70M	0.5%	-5.3%	3.368%
5/16/2022	State Street Corp	216,216	$2.15M	0.0%	+14.1%	0.349%
5/13/2022	Northern Trust Corp	170,299	$1.69M	0.0%	+64.3%	0.275%
5/13/2022	Charles Schwab Investment Management Inc.	104,034	$1.03M	0.0%	+36.6%	0.168%
5/13/2022	American International Group Inc.	11,294	$0.11M	0.0%	+92.7%	0.018%
5/13/2022	Vanguard Group Inc.	2,986,426	$29.63M	0.0%	-1.6%	4.821%
5/12/2022	BlackRock Inc.	1,162,916	$11.54M	0.0%	+54.6%	1.877%
5/12/2022	Rhumbline Advisers	19,408	$0.19M	0.0%	N/A	0.031%
5/12/2022	MetLife Investment Management LLC	15,573	$0.15M	0.0%	N/A	0.025%
5/11/2022	Bank of New York Mellon Corp	57,490	$0.57M	0.0%	+78.3%	0.093%
5/11/2022	JPMorgan Chase & Co.	20,951	$0.21M	0.0%	-59.7%	0.034%
5/5/2022	New York State Common Retirement Fund	19,410	$0.19M	0.0%	+139.6%	0.031%
2/15/2022	Adage Capital Partners GP L.L.C.	110,000	$1.85M	0.0%	+22.2%	0.178%
2/14/2022	Virtus ETF Advisers LLC	9,413	$0.16M	0.1%	N/A	0.015%
2/14/2022	Deerfield Management Company L.P. Series C	2,202,533	$37.11M	0.8%	+28.7%	3.557%
2/14/2022	Summit Rock Advisors LP	33,125	$0.56M	0.3%	N/A	0.053%
2/14/2022	HarbourVest Partners LLC	13,388	$0.23M	0.0%	N/A	0.022%
2/10/2022	Pathway Capital Management LP	242,245	$4.08M	19.6%	N/A	0.391%
2/10/2022	TD Asset Management Inc.	37,449	$0.63M	0.0%	+122.2%	0.060%
2/9/2022	Alps Advisors Inc.	71,668	$1.21M	0.0%	N/A	0.116%
2/8/2022	ProShare Advisors LLC	11,127	$0.19M	0.0%	N/A	0.018%
2/8/2022	Northern Trust Corp	103,677	$1.75M	0.0%	+5.7%	0.167%
2/3/2022	Canaan Partners XI LLC	9,663,645	$162.83M	41.9%	N/A	15.604%
2/2/2022	New York State Common Retirement Fund	8,102	$0.14M	0.0%	N/A	0.013%
12/3/2021	Perceptive Advisors LLC	556,047	$13.20M	0.2%	-26.5%	0.898%
11/16/2021	Janus Henderson Group PLC	1,022,483	$23.38M	0.0%	-21.2%	1.651%
11/16/2021	Metropolitan Life Insurance Co NY	3,636	$86K	0.0%	N/A	0.006%
11/16/2021	Millennium Management LLC	177,945	$4.22M	0.0%	N/A	0.287%
11/16/2021	BVF Inc. IL	810,284	$19.23M	0.8%	-11.8%	1.308%
11/15/2021	Deerfield Management Company L.P. Series C	1,710,730	$40.60M	0.8%	+108.9%	2.762%
11/15/2021	Rock Springs Capital Management LP	376,439	$8.93M	0.2%	+0.7%	0.608%
11/15/2021	Viking Global Investors LP	1,211,396	$28.75M	0.1%	-9.7%	1.956%
11/15/2021	Franklin Resources Inc.	590,527	$14.01M	0.0%	+13.8%	0.954%
11/12/2021	Geode Capital Management LLC	186,627	$4.43M	0.0%	+434.2%	0.301%
11/10/2021	Citigroup Inc.	1,279	$30K	0.0%	N/A	0.002%
11/9/2021	BlackRock Inc.	521,273	$12.37M	0.0%	+11,823.0%	0.842%
11/4/2021	Deutsche Bank AG	6,339	$0.15M	0.0%	N/A	0.010%
10/22/2021	Strs Ohio	2,500	$59K	0.0%	N/A	0.004%
9/17/2021	Virtu Financial LLC	12,497	$0.29M	0.0%	N/A	0.020%
8/25/2021	Marshall Wace North America L.P.	41,147	$0.94M	0.0%	N/A	0.066%
8/17/2021	Samsara BioCapital LLC	202,500	$4.61M	0.6%	N/A	0.327%
8/17/2021	Logos Global Management LP	37,069	$0.84M	0.1%	N/A	0.060%
8/17/2021	Price T Rowe Associates Inc. MD	1,505,396	$33.43M	0.0%	N/A	2.431%
8/17/2021	BVF Inc. IL	918,975	$20.93M	0.8%	N/A	1.484%
8/17/2021	Boxer Capital LLC	1,189,943	$27.10M	1.0%	N/A	1.921%
8/16/2021	Squarepoint Ops LLC	18,927	$0.43M	0.0%	N/A	0.031%
8/16/2021	LMR Partners LLP	50,000	$1.14M	0.0%	N/A	0.081%
8/16/2021	Perceptive Advisors LLC	756,047	$17.22M	0.2%	N/A	1.221%
8/16/2021	RA Capital Management L.P.	4,965,588	$113.07M	1.8%	N/A	8.018%
8/16/2021	Alyeska Investment Group L.P.	103,200	$2.35M	0.0%	N/A	0.167%
8/16/2021	Maven Securities LTD	9,000	$0.21M	0.0%	N/A	0.015%
8/16/2021	Goldman Sachs Group Inc.	11,594	$0.26M	0.0%	N/A	0.019%
8/13/2021	Northern Trust Corp	12,718	$0.29M	0.0%	N/A	0.021%
8/13/2021	Franklin Resources Inc.	518,966	$11.82M	0.0%	N/A	0.859%
8/13/2021	Geode Capital Management LLC	34,935	$0.80M	0.0%	N/A	0.058%
8/13/2021	Vanguard Group Inc.	619,384	$14.10M	0.0%	N/A	1.025%
8/13/2021	FMR LLC	2,312,450	$52.66M	0.0%	N/A	3.827%

Data available starting January 2016

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

Today's Range

Now: $20.45

$19.38

$20.49

50 Day Range

MA: $21.91

$16.44

$26.57

52 Week Range

Now: $20.45

$5.44

$28.35

Volume

19,913 shs

Average Volume

810,252 shs

Market Capitalization

$1.50 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top insider investors include:
Ai Day1 Llc (Major Shareholder)
Julie Papanek Grant (Director)
Xi LP Canaan (Major Shareholder)
Samuel C Blackman (Insider)
Jeremy Bender (CEO)
Michael Gladstone (Director)
Papanek Julie Grant (Director)
Charles N York II (CFO)
Pharmaceutical Co Ltd Takeda (Major Shareholder)
Venture Fund Xi LP Atlas (Major Shareholder)
Learn More about top insider investors at Day One Biopharmaceuticals.
Who are the major institutional investors of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top institutional shareholders include:
Atlas Venture Life Science Advisors LLC — 12.22%
FMR LLC — 9.29%
Deerfield Management Company L.P. Series C — 4.78%
Franklin Resources Inc. — 3.36%
Price T Rowe Associates Inc. MD — 2.78%
Goldman Sachs Group Inc. — 2.58%
Learn More about top institutional investors of Day One Biopharmaceuticals stock.
Which major investors are selling Day One Biopharmaceuticals stock?: During the previous quarter, DAWN stock was sold by these institutional investors:
Millennium Management LLC
Laurion Capital Management LP
Alps Advisors Inc.
Utah Retirement Systems
Virtus ETF Advisers LLC
During the previous year, company insiders that have sold Day One Biopharmaceuticals company stock include:
Ai Day1 Llc (Major Shareholder)
Julie Papanek Grant (Director)
Xi LP Canaan (Major Shareholder)
Samuel C Blackman (Insider)
Jeremy Bender (CEO)
Michael Gladstone (Director)
Papanek Julie Grant (Director)
Learn More investors selling Day One Biopharmaceuticals stock.
Which major investors are buying Day One Biopharmaceuticals stock?: Within the previous quarter, DAWN stock was acquired by institutional investors including:
FMR LLC
Goldman Sachs Group Inc.
Deerfield Management Company L.P. Series C
Franklin Resources Inc.
Atlas Venture Life Science Advisors LLC
Commodore Capital LP
Price T Rowe Associates Inc. MD
Woodline Partners LP
Within the previous year, these company insiders have bought Day One Biopharmaceuticals stock:
Ai Day1 Llc (Major Shareholder)
Julie Papanek Grant (Director)
Xi LP Canaan (Major Shareholder)
Samuel C Blackman (Insider)
Learn More investors buying Day One Biopharmaceuticals stock.